Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Memory Impairment
- Mild Cognitive Impairment
- Parkinson Disease
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentIntervention Model Description: Double-blind randomised-controlled within-subject crossover trialMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04643327
- Collaborators
- Queensland University of Technology
- Johns Hopkins University
- Cleveland Clinic Lou Ruvo Center for Brain Health
- Royal Brisbane and Women's Hospital
- Investigators
- Not Provided
Get Well Soon